These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

264 related articles for article (PubMed ID: 1314075)

  • 1. Glucocorticoids in malignant lymphoid cells: gene regulation and the minimum receptor fragment for lysis.
    Thompson EB; Nazareth LV; Thulasi R; Ashraf J; Harbour D; Johnson BH
    J Steroid Biochem Mol Biol; 1992 Mar; 41(3-8):273-82. PubMed ID: 1314075
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Cortivazol mediated induction of glucocorticoid receptor messenger ribonucleic acid in wild-type and dexamethasone-resistant human leukemic (CEM) cells.
    Ashraf J; Kunapuli S; Chilton D; Thompson EB
    J Steroid Biochem Mol Biol; 1991 May; 38(5):561-8. PubMed ID: 2039752
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Resistance of human leukemic CEM-C1 cells is overcome by synergism between glucocorticoid and protein kinase A pathways: correlation with c-Myc suppression.
    Medh RD; Saeed MF; Johnson BH; Thompson EB
    Cancer Res; 1998 Aug; 58(16):3684-93. PubMed ID: 9721879
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Suppression of c-myc is a critical step in glucocorticoid-induced human leukemic cell lysis.
    Thulasi R; Harbour DV; Thompson EB
    J Biol Chem; 1993 Aug; 268(24):18306-12. PubMed ID: 8394364
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Comparison of two structurally diverse glucocorticoid receptor agonists: cortivazol selectively regulates a distinct set of genes separate from dexamethasone in CEM cells.
    Miller AL; Webb MS; Thompson EB
    Steroids; 2007 Sep; 72(9-10):673-81. PubMed ID: 17606285
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Interactions of the phenylpyrazolo steroid cortivazol with glucocorticoid receptors in steroid-sensitive and -resistant human leukemic cells.
    Thompson EB; Srivastava D; Johnson BH
    Cancer Res; 1989 Apr; 49(8 Suppl):2253s-2258s. PubMed ID: 2702665
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Glucocorticoid effect on oncogene/growth gene expression in human T lymphoblastic leukemic cell line CCRF-CEM. Specific c-myc mRNA suppression by dexamethasone.
    Yuh YS; Thompson EB
    J Biol Chem; 1989 Jun; 264(18):10904-10. PubMed ID: 2659598
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Coordinate regulation of glucocorticoid receptor and c-jun gene expression is cell type-specific and exhibits differential hormonal sensitivity for down- and up-regulation.
    Barrett TJ; Vig E; Vedeckis WV
    Biochemistry; 1996 Jul; 35(30):9746-53. PubMed ID: 8703946
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Glucocorticoid mediated transcriptional repression of c-myc in apoptotic human leukemic CEM cells.
    Zhou F; Medh RD; Thompson EB
    J Steroid Biochem Mol Biol; 2000; 73(5):195-202. PubMed ID: 11070348
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Role of c-jun induction in the glucocorticoid-evoked apoptotic pathway in human leukemic lymphoblasts.
    Zhou F; Thompson EB
    Mol Endocrinol; 1996 Mar; 10(3):306-16. PubMed ID: 8833659
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Two glucocorticoid binding sites on the human glucocorticoid receptor.
    Srivastava D; Thompson EB
    Endocrinology; 1990 Oct; 127(4):1770-8. PubMed ID: 2205477
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Glucocorticoid receptor heterozygosity combined with lack of receptor auto-induction causes glucocorticoid resistance in Jurkat acute lymphoblastic leukemia cells.
    Riml S; Schmidt S; Ausserlechner MJ; Geley S; Kofler R
    Cell Death Differ; 2004 Jul; 11 Suppl 1():S65-72. PubMed ID: 15017388
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Glucocorticoid antagonist RU 486 reverses agonist-induced apoptosis and c-myc repression in human leukemic CEM-C7 cells.
    Thompson EB; Thulasi R; Saeed MF; Johnson BH
    Ann N Y Acad Sci; 1995 Jun; 761():261-75. PubMed ID: 7625725
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Regulation of a distinctive set of genes in glucocorticoid-evoked apoptosis in CEM human lymphoid cells.
    Thompson EB; Johnson BH
    Recent Prog Horm Res; 2003; 58():175-97. PubMed ID: 12795419
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Rapamycin sensitizes glucocorticoid resistant acute lymphoblastic leukemia CEM-C1 cells to dexamethasone induced apoptosis through both mTOR suppression and up-regulation and activation of glucocorticoid receptor.
    Guo X; Zhou CY; Li Q; Gao J; Zhu YP; Gu L; Ma ZG
    Biomed Environ Sci; 2013 May; 26(5):371-81. PubMed ID: 23611130
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [P38 mitogen-activated protein kinase mediates glucocorticoid receptor function induced by dexamethasone in acute lymphoblastic leukemia cells].
    He L; Li D; Hou KZ; Liu YP
    Zhonghua Er Ke Za Zhi; 2007 Sep; 45(9):687-91. PubMed ID: 18021564
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Glucocorticoid receptors in human leukemias and related diseases.
    Thompson EB; Smith JR; Bourgeois S; Harmon JM
    Klin Wochenschr; 1985 Aug; 63(15):689-98. PubMed ID: 2413243
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Constitutive expression of ectopic c-Myc delays glucocorticoid-evoked apoptosis of human leukemic CEM-C7 cells.
    Medh RD; Wang A; Zhou F; Thompson EB
    Oncogene; 2001 Aug; 20(34):4629-39. PubMed ID: 11498786
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Dysfunctional glucocorticoid receptor with a single point mutation ablates the CCAAT/enhancer binding protein-dependent growth suppression response in a steroid-resistant rat hepatoma cell variant.
    Ramos RA; Meilandt WJ; Wang EC; Firestone GL
    FASEB J; 1999 Jan; 13(1):169-80. PubMed ID: 9872941
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The distinct agonistic properties of the phenylpyrazolosteroid cortivazol reveal interdomain communication within the glucocorticoid receptor.
    Yoshikawa N; Yamamoto K; Shimizu N; Yamada S; Morimoto C; Tanaka H
    Mol Endocrinol; 2005 May; 19(5):1110-24. PubMed ID: 15677712
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.